Cathie Wood's ARK Buys RXRX, NTLA, VCYT Stocks While Selling $18M TWST
Cathie Wood's ARK Invest bought approximately 1.48 million shares of Recursion Pharmaceuticals (RXRX), 96,308 shares of Intellia Therapeutics (NTLA), and 115,472 shares of Veracyte (VCYT) across ARK Genomic Revolution ETF (ARKG) and ARK Innovation ETF (ARKK) on Monday, while selling 90,713 shares of
GateMacroTradfiHub·10-06 14:15
